Dopamine and Mania: Behavioral and Biochemical Effects of the Dopamine Receptor Blocker Pimozide

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1980 Jan 1

PMID 6155678

Citations 18

Authors

R M Post

D C Jimerson

W E Bunney Jr

F K Goodwin

Affiliations

Soon will be listed here.

Abstract

Although recent data suggest that pimozide has effects at other neurotransmitter receptor sites, it is one of the more specific neuroleptics in its effects on dopamine receptors. We report that in manic patients pimozide produces substantial clinical improvement with a magnitude and time course similar to that observed with the more routinely used phenothiazines chlorpromazine and thioridazine. Pimozide did not significantly increase probenecid-induced accumulations of the dopamine metabolite homovanillic acid (HVA) compared to pretreatment values. Higher HVA values were observed in manic than in nonmanic patients, however. These clinical and biochemical data add to a growing body of indirect evidence that a dopaminergic alteration may be associated with some components of the manic syndrome.

Citing Articles

Lithium for acute mania.

McKnight R, de La Motte de Broons de Vauvert S, Chesney E, Amit B, Geddes J, Cipriani A Cochrane Database Syst Rev. 2019; 6:CD004048.

PMID: 31152444 PMC: 6544558. DOI: 10.1002/14651858.CD004048.pub4.

Pimozide: An Old Wine in a New Bottle!.

Naguy A Indian J Psychol Med. 2017; 39(3):382-383.

PMID: 28615787 PMC: 5461863. DOI: 10.4103/IJPSYM.IJPSYM_400_16.

Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.

Rapoport S ACS Chem Neurosci. 2014; 5(6):459-67.

PMID: 24786695 PMC: 4063504. DOI: 10.1021/cn500058v.

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report.

Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa S Neuropsychiatr Dis Treat. 2014; 10:507-11.

PMID: 24707175 PMC: 3971947. DOI: 10.2147/NDT.S58302.

A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.

Liang Q, Dexheimer T, Zhang P, Rosenthal A, Villamil M, You C Nat Chem Biol. 2014; 10(4):298-304.

PMID: 24531842 PMC: 4144829. DOI: 10.1038/nchembio.1455.

References

Yamamura H, Manian A, Snyder S . Muscarinic cholinergic receptor binding: influence of pimozide and chlorpromazine metabolites. Life Sci. 1976; 18(7):685-91. DOI: 10.1016/0024-3205(76)90179-x. View

Pert A, Rosenblatt J, Sivit C, Pert C, Bunney Jr W . Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science. 1978; 201(4351):171-3. DOI: 10.1126/science.566468. View

van Praag H, Korf J . Serotonin metabolism in depression: clinical application of the probenecid test. Int Pharmacopsychiatry. 1974; 9(1):35-51. DOI: 10.1159/000468114. View

Baudry M, Martres M, Schwartz J . In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists. Life Sci. 1977; 21(8):1163-70. DOI: 10.1016/0024-3205(77)90116-3. View

Post R, Goodwin F . Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients. Science. 1975; 190(4213):488-9. DOI: 10.1126/science.1166321. View

Sack R, Goodwin F . Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid. Arch Gen Psychiatry. 1974; 31(5):649-54. DOI: 10.1001/archpsyc.1974.01760170049008. View

Creese I, Iversen S . The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia. 1974; 39(4):345-57. DOI: 10.1007/BF00422974. View

Ettenberg A, Milner P . Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats. Pharmacol Biochem Behav. 1977; 7(6):507-14. DOI: 10.1016/0091-3057(77)90246-5. View

van Rossum J . Mode of action of psychomotor stimulant drugs. Int Rev Neurobiol. 1970; 12:307-83. DOI: 10.1016/s0074-7742(08)60065-3. View

10.

Spitzer R, Endicott J, Robins E . Clinical criteria for psychiatric diagnosis and DSM-III. Am J Psychiatry. 1975; 132(11):1187-92. DOI: 10.1176/ajp.132.11.1187. View

11.

Gianutsos G, Thornburg J, Moore K . Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine. Psychopharmacology (Berl). 1976; 50(3):225-9. DOI: 10.1007/BF00426836. View

12.

Goodwin F, Post R, Dunner D, Gordon E . Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am J Psychiatry. 1973; 130(1):73-9. DOI: 10.1176/ajp.130.1.73. View

13.

Seeman P, Tedesco J, Lee T, Muller P, Bowles J, Whitaker P . Dopamine receptors in the central nervous system. Fed Proc. 1978; 37(2):131-6. View

14.

Horn A, Phillipson O . A noradren aline sensitive adenylate cyclase in the rat limbic forebrain: preparation, properties and the effects of agonists, adrenolytics and neuroleptic drugs. Eur J Pharmacol. 1976; 37(1):1-11. DOI: 10.1016/0014-2999(76)90002-9. View

15.

Friedman E, Gershon S . Effect of lithium on brain dopamine. Nature. 1973; 243(5409):520-1. DOI: 10.1038/243520a0. View

16.

Kolivakis T, Azim H, Kingstone E . A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients. Curr Ther Res Clin Exp. 1974; 16(9):998-1004. View

17.

Creese I, Burt D, Snyder S . Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976; 192(4238):481-3. DOI: 10.1126/science.3854. View

18.

van Praag H . The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia. Br J Psychiatry. 1977; 130:463-74. DOI: 10.1192/bjp.130.5.463. View

19.

Goldberg J, Kurland A . Pimozide in the treatment of behavioral disorders of hospitalized adolescents. J Clin Pharmacol. 1974; 14(2):134-9. DOI: 10.1002/j.1552-4604.1974.tb02303.x. View

20.

Sedvall G, Fyro B, Nyback H, Wiesel F . Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. J Psychiatr Res. 1974; 11:75-80. DOI: 10.1016/0022-3956(74)90075-2. View